The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Impact of cholangiocarcinoma (CC) molecular heterogeneity on outcome during first-line chemotherapy and access to targeted therapies in early clinical trials (CT).
 
Helena Verdaguer
No Relationships to Disclose
 
Irene Brana
No Relationships to Disclose
 
Cinta Hierro
No Relationships to Disclose
 
Analia Azaro
Consulting or Advisory Role - Orion
 
Elena Elez
No Relationships to Disclose
 
Elena Garralda
Consulting or Advisory Role - Roche
 
Berta Laquente
No Relationships to Disclose
 
Juan Francisco Grau Bejar
No Relationships to Disclose
 
Fiorella Ruiz-Pace
No Relationships to Disclose
 
Cristina Viaplana
No Relationships to Disclose
 
Susana Aguilar
No Relationships to Disclose
 
Rodrigo Dienstmann
Consulting or Advisory Role - Astellas Pharma; Novartis; Roche/Genentech
Research Funding - Merck
 
Teresa Macarulla Mercade
No Relationships to Disclose